Citation Impact
Citing Papers
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Morphology of sporadic colorectal cancer with DNA replication errors
1998
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
2004
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
Recurrent inflammatory pseudotumors in children
2003
A Case of Imported Melioidosis Presenting as Prostatitis
2003
Prognostic Factors in Colorectal Cancer
2000
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Pulmonary Complications of Down Syndrome during Childhood
2010
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Inflammatory pseudotumors of the central nervous system: Report of 3 cases and a literature review
2003
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
Internal validation of predictive models
2001 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors
2001
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.
1996
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Colorectal cancer
2013 Standout
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
2015 Standout
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
2006
Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells
2008
Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm
1995
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
1995
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
1992
Hereditary Colorectal Cancer
2003 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
1997
Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors
2011
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Reactive oxygen species in cancer
2010 Standout
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
1997
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.
1997
Assessing the Performance of Prediction Models
2009 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
Comparison of the Prognostic Value of Inflammation-Based Pathologic and Biochemical Criteria in Patients Undergoing Potentially Curative Resection for Colorectal Cancer
2009
Health Supervision for Children With Down Syndrome
2011 Standout
American Joint Committee on Cancer prognostic factors consensus conference
2000
Cancer-related inflammation and treatment effectiveness
2014 Standout
Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
2004
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
2001
A multicenter randomized phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma
1998
ROS signalling in the biology of cancer
2017 Standout
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
2004
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Inflammatory pseudotumors of the lung
1999
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a hellenic co-operative oncology group study
1996
High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)
2000
Cancer of the Ovary
2004 Standout
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer
2001
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
1998
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
2014 Standout
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.
2000
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
Methodologic Guide for Evaluating Clinical Performance and Effect of Artificial Intelligence Technology for Medical Diagnosis and Prediction
2018 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
2003
Angiogenic imbalance in pre‐eclampsia and fetal growth restriction: enhanced soluble fms‐like tyrosine kinase‐1 binding or diminished production of placental growth factor?
2022
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Combined Intraperitoneal and Intravenous Chemotherapy for Women With Optimally Debulked Ovarian Cancer: Results From an Intergroup Phase II Trial
2003
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Intraperitoneal treatment and dose-intense therapy in ovarian cancer
1999
Congenital Malformations
1953 Standout
Assessing the Generalizability of Prognostic Information
1999
New concepts in the pathology of congenital lung malformations
2003
American Joint Committee on Cancer Prognostic Factors Consensus Conference
1999
Works of Yuen Chan being referenced
Metachronous Pulmonary and Cerebral Inflammatory Pseudotumor in a child
1994
A Randomized Study of High-Dose versus Low-Dose cis-Platinum Combined with Cyclophosphamide in the Treatment of Advanced Ovarian Cancer
1989
Acute Disseminated Melioidosis Presenting as Acute Retention of Urine
1991
Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction
2016
Pulmonary sequestration presenting as a prenatally detected suprarenal lesion in a neonate
2000
Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer
1996
Subpleural lung cysts in Down's syndrome
1999